“Cut-To-The-Chase” Members Make 122%
Potential Profit On This Options Trade!

Cronos Group soared on Wednesday
after midterm elections and Jeff Sessions resignation boosting the stock price.
An option call trade
was recommended to “Cut-To-The-Chase”
Members on Thursday, November 01, 2018, originally having the distinction
of being the best-performing marijuana stock of all time right now. Despite
having seen a pullback over the past few weeks, Cronos has posted gains of more
than 2,700% over the past few years. Having formerly been known as PharmaCan
Capital, Cronos has been a big player in the medical marijuana segment of the
cannabis industry. This has enabled Stock Options Made Easy members to see a
potential profit of 122% in less than a week.

On
October 17, Canada officially lifted the gate on recreational marijuana sales
to adults. Once legal, sales soared, with the industry expected to pull in up
to $5 billion in added annual sales when fully ramped up. The expectation of
billions of dollars in added revenue into marijuana stocks is expected. One
company that has benefited from this situation is Cronos Group Inc (NASDAQ: CRON).Marijuana stocks have produced
amazing gains, and now that they're squarely on the radar of mainstream
investors.

In response to the recent legalization efforts in Canada, Cronos CEO
Mike Gorenstein, stated, "At Cronos,
we take pride in leading the industry forward responsibly and are motivated to
create meaningful products that excite our consumers and bring happiness and an
improved quality of life. The growth potential in the cannabis industry is vast
and extends well beyond the flower. With our differentiated brands, global
footprint, growing production capacity and commitment to cannabinoid
innovation, Cronos is well positioned to realize this opportunity."

Cronos
Group has the distinction of being the best-performing marijuana stock of all
time right now. Despite having seen a pullback over the past few weeks, Cronos
has posted gains of more than 2,700% over the past few years. Having formerly
been known as PharmaCan Capital, Cronos has been a big player in the medical
marijuana segment of the cannabis industry.

Like
Canopy, Cronos has worked hard to boost its production capacity. Another avenue
for growth involves international distribution, with partnerships giving it
access to markets in Australia, Israel, Germany, Poland, and various points in
Latin America. With a new collaboration with Ginkgo Bioworks to develop
cannabis derivatives of high purity, Cronos hopes it can tap into growing
markets for both medicinal and recreational use. If it's successful, that could
lead to even bigger gains for Cronos.

The cannabis industry has quickly taken off,
especially after the midterm elections and the resignation of Attorney General
Jeff Sessions.

Paul
Rosen, currently the CEO and Chairman of Tidal Royalty, a company that invests
in U.S.-based cannabis companies, as well as an original co-founder of the
Cronos Group (TSX: CRON), (NASDAQ:CRON)
was quoted as saying, “I believe that
Michigan legalizing adult use will one day be viewed as the tipping point
towards full legalization at a national level. Aside from the fact that it is
the 10th state to legalize adult use – and one of the most populous states in
the nation – it is the first Midwest state to do so.”

Not only
was Cronos lifted by midterm ballot measure victories, but also rose further on
word Sessions had resigned. The nation's top law enforcer last January said he
would work to revoke policy from the Obama administration that let states make
their own rules on weed without hindrance from the federal government.

The Profits.....

So, for
“Cut-To-The-Chase” members, who managed to execute this trade recommended by
Stock Options Made Easy; potential profits of 122% were available Wednesday.

Entering
the option trade at a cost of $1.30 or less; and the sell price on the option,
at Wednesday trading reaching $2.88; a potential profit of 122% is applicable.
Therefore, one options contract would provide a profit of $158.00 in less than
one week.

A NICE FINISH TO THE WEEK!

What
now…..

As cannabis stocks continue to rise on the
news of more and more favorable legislation, the next big development will
perhaps be the passing of the 2018 U.S. Farm Bill under a new Democrat House.

Collin Peterson, ranking member and
presumptive new chair of committee, said “passing
the crucial agricultural legislation was going to be his top priority, with a
deal possible as soon as next week during the lame-duck session.”

CONCLUSION…….

As you
would have by now realized, some of our trades are based on earnings
predictions. This is not to say all trades recommended to members follow this
pattern, but it is obvious that this was not the situation in this instance. But,
during earnings season this strategy of predicting earnings has been very
profitable.

Sometimes it is our approach to predict
whether a company will beat or miss estimates, whether the stock will
appreciate or depreciate as a result and what strategies investors and traders
can use – such as found with the “Earnings Predictions Program”. This type of
prediction is based on thorough investigation and fundamentally based research,
and the results have been very exceptional.

It is also worth
considering, when options trading earnings reports – “Do we exit on
already existing profits or leave the companies to report their earnings and
hope for bigger profit?”.....READ MORE.....